Summary of Aoki Technology's Conference Call Company Overview - **Company**: Aoki Technology - **Acquisition Target**: Omega Brand - **Acquisition Amount**: Approximately 200 million RMB for 65.83% stake Key Points Industry and Market Potential - The health supplement industry in China is projected to reach a total market size of approximately 400 to 450 billion RMB in 2024, with an annual growth rate of 15% to 20% [6][12] - The fish oil segment is particularly strong, with online sales reaching 8.2 billion RMB from January to October 2025, representing a 36% year-on-year growth [6] Acquisition Details - Aoki Technology will acquire Omega Brand through a two-step process: purchasing existing shares and increasing capital, totaling 150 million Norwegian Krone (approximately 100 million RMB) [3][8] - The valuation is based on a 10.8 times price-to-earnings ratio for 2024 net profit, which is expected to become more attractive with a projected annual growth rate of over 35% [2][8] Financial Impact - The acquisition is expected to add over 500 million RMB to Aoki's annual profits, with a net profit margin anticipated to exceed 10% [2][9] - Aoki aims for Omega Brand to achieve over 1 billion RMB in revenue by 2027-2028, with a target of 35% growth compared to 2025 [4][12] Strategic Integration - Aoki plans to enhance Omega's supply chain, improve R&D capabilities, and expand into global markets [10] - The company will leverage existing online and offline channels, aiming for a balanced sales distribution between both [11] Product Development and Marketing - Aoki will focus on extending product lines around seal oil, fish oil, and astaxanthin, targeting cardiovascular health and expanding into brain health and eye care [11][16] - The company intends to utilize its marketing resources and consumer insights to support the new brand's growth [26] Competitive Advantages - Aoki has a strong position in the seal oil market due to its close relationships with upstream suppliers, which provides a competitive edge [13][15] - The company plans to differentiate itself in the health supplement sector by enhancing R&D for various products [15] Future Outlook - Aoki's current market share in China is approximately 80%, with plans to expand into Southeast Asia, Europe, and the Americas [14] - The company expects to see an increase in net profit margins as brand scale effects become more pronounced, with a projected net profit margin exceeding 25% [22][28] Operational Strategy - The new acquisition will be operated independently by Aoki's wholly-owned subsidiary, with expectations of significant revenue contributions in the coming years [24][25] - Aoki is also considering expanding into health food products in the long term, while focusing on existing supplement lines in the short term [17] Sales Performance - During the Double Eleven shopping festival, Aoki achieved a sales completion rate of over 100%, with a lower return rate compared to the previous year [23] This summary encapsulates the strategic direction, financial implications, and market positioning of Aoki Technology following its acquisition of Omega Brand, highlighting the company's growth potential in the health supplement industry.

Investment Rating - The investment rating for the company is "Buy" (maintained) [7] Core Insights - The company is experiencing revenue pressure in H1 2025, primarily due to high gold prices leading to conservative inventory purchases by franchisees and store closures. However, the company is actively adjusting its product category structure, increasing the proportion of high-margin products such as IP series, fixed-price gold, embedded products, and bracelets, resulting in a net profit growth of over 30% in Q2 2025 [5][12] - The comprehensive gross profit margin for H1 2025 is 30.3%, an increase of 11.96 percentage points year-on-year. The sales expense ratio is 10.8%, up by 4.34 percentage points year-on-year, and the net profit margin attributable to the parent company is 12.92%, an increase of 5.58 percentage points year-on-year [5][12] Financial Performance Summary - H1 2025 revenue is reported at 4.597 billion, a year-on-year decrease of 43.9%. The net profit attributable to the parent company is 594 million, a decrease of 1.3% year-on-year. In Q2 2025, revenue is 1.924 billion, down 38.5% year-on-year, while net profit is 342 million, up 31.3% year-on-year [11][12] - The company has outlined five strategic directions for the future: brand matrix development, new retail transformation, organizational change, deep digitalization, and brand expansion overseas. Significant investments will be made in these areas over the next two to three years [13] - Revenue forecasts for 2025-2027 are 11.738 billion, 12.971 billion, and 13.943 billion, with corresponding growth rates of -15.5%, 10.5%, and 7.5%. Net profit attributable to the parent company is projected at 1.110 billion, 1.213 billion, and 1.269 billion, with growth rates of 9.9%, 9.3%, and 4.6% respectively [14]

Group 1 - The company reported a robust revenue growth of 17.29% year-on-year, achieving an operating income of 4.108 billion yuan in H1 2025 [1] - The net profit attributable to the parent company reached 524 million yuan, reflecting a significant increase of 30.65% year-on-year [1] - The gross margin for H1 2025 was 75.52%, a slight decrease of 0.99 percentage points, while the net profit margin improved by 1.74 percentage points to 13.52% [1] Group 2 - The main brand, Han Shu, generated revenue of 3.344 billion yuan in H1 2025, marking a 14.3% increase, with significant sales from the Hong Man Yao and X Peptide series [2] - The second brand, Newpage, saw a remarkable revenue growth of 146.5% year-on-year, reaching 397 million yuan, achieving its annual sales target for 2024 [2] - The company is actively enhancing its online sales strategy, with self-operated online channels generating 3.421 billion yuan in revenue, a 24.6% increase, and accounting for 83.3% of total revenue [2] Group 3 - The company is expected to achieve net profits of 1.025 billion yuan, 1.286 billion yuan, and 1.566 billion yuan for the years 2025, 2026, and 2027, respectively, with corresponding PE ratios of 32, 26, and 21 [3]

Investment Rating - The report maintains a "Buy" rating for the company [4][7]. Core Insights - The company reported a robust revenue growth of 17.29% year-on-year, achieving a total revenue of 4.108 billion yuan in H1 2025. The net profit attributable to the parent company reached 524 million yuan, reflecting a significant increase of 30.65% [1]. - The gross margin for H1 2025 was 75.52%, a slight decrease of 0.99 percentage points year-on-year, while the net profit margin improved by 1.74 percentage points to 13.52% [1]. - The company effectively managed its expenses, with a sales expense ratio of 56.88%, down by 0.69 percentage points, and a management expense ratio of 3.72%, up by 0.47 percentage points [1]. Revenue Breakdown - The main brand, Han Shu, generated revenue of 3.344 billion yuan in H1 2025, marking a year-on-year growth of 14.3%. The secondary brand, Newpage, saw a remarkable revenue increase of 146.5% to 397 million yuan [2]. - The company launched several new products across various categories, including a high-end anti-aging skincare brand, and is preparing to introduce a well-known IP licensed baby brand [2]. Online Sales Strategy - The company has strengthened its online sales strategy, particularly on the Douyin platform, where the Han Shu brand consistently ranks first in GMV. Online self-operated channels generated 3.421 billion yuan in revenue, a 24.6% increase year-on-year, accounting for 83.3% of total revenue [3]. Profit Forecast - The company is projected to achieve net profits of 1.025 billion yuan, 1.286 billion yuan, and 1.566 billion yuan for the years 2025, 2026, and 2027, respectively, with corresponding P/E ratios of 32, 26, and 21 [4].

Core Insights - The company reported a revenue of 2.941 billion yuan for the first half of 2025, representing a year-on-year growth of 19.58%, with a net profit attributable to shareholders of 373 million yuan, up 16.7% [1] - The company focuses on six core product categories and has successfully built a brand matrix, achieving a global presence for its konjac products [4] Financial Performance - In Q2 2025, the company achieved a revenue of 1.403 billion yuan, a year-on-year increase of 13.54%, and a net profit of 195 million yuan, up 21.75% [1] - The gross profit margin for H1 2025 was 29.66%, down 2.87 percentage points year-on-year, with specific product margins varying [2] - The expense ratio significantly decreased in Q2 2025 to 15.21%, down 5.19 percentage points year-on-year, contributing to a notable increase in net profit margins [3] Product and Channel Performance - The company saw high growth in konjac products and egg snacks, with konjac product revenue increasing by 155.10% year-on-year [1] - Direct sales channel revenue decreased by 42% year-on-year, while distribution and other channels grew by 30.09% [1] - The company is expanding its presence in overseas markets, achieving revenue of 96.35 million yuan in H1 2025, a 54% increase from the previous half [2] Strategic Focus - The company is enhancing its brand strategy by leveraging a dual-brand approach, combining a well-known main brand with sub-brands to strengthen market positioning [4] - The marketing strategy includes a focus on full-channel development, with significant efforts in e-commerce and new retail channels [5] Future Outlook - Revenue projections for 2025-2027 are 6.519 billion, 8.010 billion, and 9.265 billion yuan, with expected net profits of 813 million, 1.040 billion, and 1.225 billion yuan respectively, indicating strong growth potential [5]

Investment Rating - The investment rating for the company is "Outperform the Market" [6][4][18] Core Views - The company's performance is under pressure due to multiple factors, including disappointing sales during major promotional events and high marketing costs on platforms like Douyin. The net profit for 2024 is expected to decline by 33.53% year-on-year, while revenue is projected to grow by 3.87% [1][7] - The main brand, Winona, continues to have strong consumer recognition in the sensitive skin care sector, despite short-term performance challenges. The company is actively expanding into the medical beauty and health sectors, which may drive long-term growth [4][18] - The company is currently in a brand matrix development and channel strategy transformation phase, with high expense ratios impacting profitability during this transition [4][18] Financial Performance Summary - For 2024, the company is expected to achieve revenue of 57.36 billion, a year-on-year increase of 3.87%, and a net profit of 5.03 billion, a year-on-year decrease of 33.53% [1][7] - The first quarter of 2025 shows a revenue of 9.49 billion, down 13.51% year-on-year, and a net profit of 0.28 billion, down 83.97% year-on-year [8] - The gross margin for 2024 is projected at 73.74%, a slight decrease of 0.16 percentage points year-on-year, while the first quarter of 2025 shows an improvement in gross margin to 77.47% [12][3] Brand and Channel Performance - In 2024, the main brand Winona generated revenue of 49.1 billion, a decrease of 2.8% year-on-year, while the sub-brand Winona Baby saw a revenue increase of 34.03% to 2 billion [2][8] - Online sales channels achieved revenue of 39.12 billion in 2024, a year-on-year increase of 10.13%, with significant growth on platforms like Douyin and JD [9][2] - The offline channel revenue decreased by 10.72% year-on-year to 12.74 billion, indicating a shift in consumer purchasing behavior towards online platforms [9][2] Expense and Profitability Metrics - The sales expense ratio for 2024 is projected to increase by 2.71 percentage points year-on-year to 49.97%, reflecting higher marketing investments [12][3] - The company plans to distribute a cash dividend of 6 yuan per 10 shares for 2024, representing a payout ratio of 50% of net profit [1][7] - The net profit forecast for 2025-2026 has been revised down to 6.87 billion and 8.22 billion, respectively, due to prolonged new product development cycles and high expense ratios during the transformation period [4][18]